Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Erythromycin, cutaneous

Generic name
Erythromycin, cutaneous
Brand name
ATC Code
D10AF02

Pharmacokinetics in children

No studies have been carried out into the pharmacokinetic parameters of cutaneous erythromycin in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Acne vulgaris
  • Cutaneous
    • 10 years up to 18 years
      • 2% formulation of erythromycine: apply to the affected areas twice daily (in the morning and in the evening). In the event of side effects, lower the frequency to once daily

      • According to the NHG (Dutch College of General Practitioners) standard for acne of 2017: In combination with benzoyl peroxide, adapalene or tretinoin: 1% erythromycin once daily in the morning combined with once daily benzoyl peroxide/adapalene or tretinoin in the evening, minimum 6 weeks and maximum 6 months.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

Itching, erythema, burning sensation, dryness, flaking,

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. Lesher JL Jr,et al, An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris, J Am Acad Dermatol., 1985, Mar;12(3), 526-31
  2. Shahlita AR, Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison, Arch Dermatol, 1984, Mar;120(3), 351-5
  3. Rapaport M, et al, Evaluation of topical erythromycin and oral tetracycline in acne vulgaris, Cutis. :,, 1982, Jul;30(1), 122-6, 130, 132-5
  4. Pochi PE, et al, Erythromycin 2 percent gel in the treatment of acne vulgaris, Cutis, 1988 Feb, 41(2), 132-6
  5. Glass D, et al, A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris, Dermatology, 1999, 199(3), 242-7
  6. Bruinsma M, et al, NHG Standaard Acne (derde herziening), Huisarts Wet, 2017 (april)

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes